Research and Development Agreements - Schedule of Research and Development Revenue from Related Party Relates to Revenue from Research and Development Agreements (Detail) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
|
Revenue Recognition [Line Items] | ||
Total research and development revenue | $ 1,800 | $ 6,413 |
Millennium Pharmaceuticals Inc | ||
Revenue Recognition [Line Items] | ||
Total research and development revenue | 333 | 6,413 |
Millennium Pharmaceuticals Inc | Takeda Individual Project Agreement | ||
Revenue Recognition [Line Items] | ||
Total research and development revenue | 0 | 54 |
Millennium Pharmaceuticals Inc | Takeda Development Agreement | ||
Revenue Recognition [Line Items] | ||
Total research and development revenue | 147 | 6,114 |
Millennium Pharmaceuticals Inc | Takeda Multi Target Agreement | ||
Revenue Recognition [Line Items] | ||
Total research and development revenue | $ 186 | $ 245 |
X | ||||||||||
- Definition Research and development revenues from collaboration agreements. No definition available.
|
X | ||||||||||
- Definition Revenue recognition. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|